PRE Prenetics: Rasio rega marang prakiraan pendapatan

Simbol lan logo merek Prenetics Global Limited (PRE)

Prenetics Global (PRE) ensures high profitability through the express delivery of biological samples to laboratories. The forward P/S trend clearly demonstrates the risk of overpaying for the asset, while 1.80 reflects the latest metric value. Growth is driven by demand for personalized medicine in Asia, and an optimized transportation network completely eliminates diagnostic delays.

Prenetics Global Ltd - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep PRE (periode 28.04.2023 - 13.11.2026)

Rincian analitis perusahaan Prenetics Global

- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
Analisis kabeh metrik perusahaan:PRE (Prenetics Global Ltd)
Sampel barang prenetics.com

Prenetics Global (PRE) maintains a dominant position in Asian genetics, driven by CircleDNA patents and stringent regulatory barriers. The GURU.Markets tool for calculating the business's future P/S allows for the comparison of projected revenue with gross margin, filtering out market noise; an increase in this multiple indicates expectations of expansion, yet warns the investor of the risk of overpaying for the asset.

Analisis perusahaan pesaing

Multiplikator Forward P/S A (Agilent)|Quest Diagnostics Inc. (DGX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ILMN - Rasio rega marang prakiraan pendapatan|EXAS (Exact Sciences Inc.) - Kapitalisasi marang prakiraan pendapatan|RVTY: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep bio-rad.com (BIO)|Multiplikator forward rega marang pendapatan NNNN|SHC (Sotera Health Corp) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S QDEL|Rasio kapitalisasi marang dodolan sing dikarepake OPKO Health Corp.|Multiplikator Forward P/S CDNA (CareDx, Inc)|MRVI - Multiplikator forward rega marang pendapatan|FLGT - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Standard BioTools Inc LAB|CTKB (Cytek Bio) - Multiplikator forward rega marang pendapatan|OraSure Corp - Rega forward marang dodolan|XGN (Exagen Inc) - Multiplikator Forward P/S|MDXH - Prakiraan rega marang pendapatan|Rasio rega marang prakiraan pendapatan Lucid Diagnostics (LUCD)|Rasio rega marang prakiraan pendapatan IMDX (imdxinc.com)|Rasio rega marang prakiraan pendapatan Trinity Biotech TRIB|ProPhase Labs Corp (PRPH) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Ainos, Inc. - Multiplikator Forward P/S|CODX: Rasio rega marang prakiraan pendapatan|HSCS: Multiplikator Forward P/S|Biomerica Inc. (BMRA) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Cardio Diagnostics Holdings Inc.|Rasio rega marang prakiraan pendapatan ONCO|Rasio rega marang prakiraan pendapatan Virax Biolabs Group (VRAX)|BJDX: Rega mangsa ngarep marang pendapatan|Rasio rega marang prakiraan pendapatan Aspira Women's Health Inc. AWH|Rega forward marang dodolan AXDX|centogene.com - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Enzo Biochem, Inc.|fresh2.co (FRES) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Genetic Technologies Limited|ME (23andMe) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Psychemedics Corp. PMD